Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-25 @ 3:57 AM
NCT ID:
NCT04574102
Brief Summary:
The objective of this study is to evaluate the safety and effectiveness of the
investigational Omega Refractive Capsule (model V)
Detailed Description:
This study is a prospective, interventional, randomized, controlled, paired eye, subject-masked design.
Subjects will be randomly assigned to which eye will receive the Omega Refractive capsule V with an FDA approved intraocular lens. Fellow eyes will serve as controls and receive an FDA approved IOL (no Omega capsule).
Study:
NCT04574102
Study Brief:
Protocol Section:
NCT04574102